1
|
Chagaleti BK, B SK, G V A, Rajagopal R, Alfarhan A, Arockiaraj J, Muthu Kumaradoss K, Karthick Raja Namasivayam S. Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation - A systematic computational approach to discover novel cancer therapeutics. Comput Biol Chem 2024; 112:108134. [PMID: 38964206 DOI: 10.1016/j.compbiolchem.2024.108134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2024] [Accepted: 06/20/2024] [Indexed: 07/06/2024]
Abstract
Global public health is confronted with significant challenges due to the prevalence of cancer and the emergence of treatment resistance. This work focuses on the identification of cyclin-dependent kinase 2 (CDK2) through a systematic computational approach to discover novel cancer therapeutics. A ligand-based pharmacophore model was initially developed using a training set of seven potent CDK2 inhibitors. The obtained most robust model was characterized by three features: one donor (|Don|) and two acceptors (|Acc|). Screening this model against the ZINC database resulted in identifying 108 hits, which underwent further molecular docking studies. The docking results indicated binding affinity, with energy values ranging from -6.59 kcal mol⁻¹ to -7.40 kcal mol⁻¹ compared to the standard Roscovitine. The top 10 compounds (Z1-Z10) selected from the docking data were further screened for ADMET profiling, ensuring their compliance with pharmacokinetic and toxicological criteria. The top 3 compounds (Z1-Z3) chosen from the docking were subjected to Density Functional Theory (DFT) studies. They revealed significant variations in electronic properties, providing insights into the reactivity, stability, and polarity of these compounds. Molecular dynamics simulations confirmed the stability of the ligand-protein complexes, with acceptable RMSD and RMSF values. Specifically, compound Z1 demonstrated stability, around 2.4 Å, and maintained throughout the 100 ns simulation period with minimal conformational changes, stable RMSD, and consistent protein-ligand interactions.
Collapse
Affiliation(s)
- Bharath Kumar Chagaleti
- Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu District, Kattankulathur, Tamil Nadu 603203, India
| | - Shantha Kumar B
- Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu District, Kattankulathur, Tamil Nadu 603203, India
| | - Anjana G V
- Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu District, Kattankulathur, Tamil Nadu 603203, India
| | - Rajakrishnan Rajagopal
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box No. 2455, Riyadh 11451, Saudi Arabia
| | - Ahmed Alfarhan
- Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box No. 2455, Riyadh 11451, Saudi Arabia
| | - Jesu Arockiaraj
- Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Chengalpattu District, Kattankulathur, Tamil Nadu 603203, India.
| | - Kathiravan Muthu Kumaradoss
- Dr. APJ Kalam Research Lab, Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Chengalpattu District, Kattankulathur, Tamil Nadu 603203, India.
| | - S Karthick Raja Namasivayam
- Centre for Applied Research, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu 602105, India.
| |
Collapse
|
2
|
Popiołek Ł, Gawrońska-Grzywacz M, Dziduch A, Biernasiuk A, Piątkowska-Chmiel I, Herbet M. Design, Synthesis, and In Vitro and In Vivo Bioactivity Studies of Hydrazide-Hydrazones of 2,4-Dihydroxybenzoic Acid. Int J Mol Sci 2023; 24:17481. [PMID: 38139308 PMCID: PMC10743905 DOI: 10.3390/ijms242417481] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2023] [Revised: 11/28/2023] [Accepted: 12/05/2023] [Indexed: 12/24/2023] Open
Abstract
In this research, twenty-four hydrazide-hydrazones of 2,4-dihydroxybenzoic acid were designed, synthesized, and subjected to in vitro and in vivo bioactivity studies. The chemical structure of the obtained compounds was confirmed by spectral methods. Antimicrobial activity screening was performed against a panel of microorganisms for all synthesized hydrazide-hydrazones. The performed assays revealed the interesting antibacterial activity of a few substances against Gram-positive bacterial strains including MRSA-Staphylococcus aureus ATCC 43300 (compound 18: 2,4-dihydroxy-N-[(2-hydroxy-3,5-diiodophenyl)methylidene]benzohydrazide-Minimal Inhibitory Concentration, MIC = 3.91 µg/mL). In addition, we performed the in vitro screening of antiproliferative activity and also assessed the acute toxicity of six hydrazide-hydrazones. The following human cancer cell lines were used: 769-P, HepG2, H1563, and LN-229, and the viability of the cells was assessed using the MTT method. The HEK-293 cell line was used as a reference line. The toxicity was tested in vivo on Danio rerio embryos using the Fish Embryo Acute Toxicity (FET) test procedure according to OECD No. 236. The inhibitory concentration values obtained in the in vitro test showed that N-[(4-nitrophenyl)methylidene]-2,4-dihydroxybenzhydrazide (21) inhibited cancer cell proliferation the most, with an extremely low IC50 (Inhibitory Concentration) value, estimated at 0.77 µM for LN-229. In addition, each of the compounds tested was selective against cancer cell lines. The compounds with a nitrophenyl substituent were the most promising in terms of inhibition cancer cell proliferation. The toxicity against zebrafish embryos and larvae was also very low or moderate.
Collapse
Affiliation(s)
- Łukasz Popiołek
- Chair and Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki Street, 20-093 Lublin, Poland;
| | - Monika Gawrońska-Grzywacz
- Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 8B Jaczewskiego Street, 20-090 Lublin, Poland; (M.G.-G.); (I.P.-C.); (M.H.)
| | - Aleksandra Dziduch
- Chair and Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Lublin, 4A Chodźki Street, 20-093 Lublin, Poland;
| | - Anna Biernasiuk
- Chair and Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Medical University of Lublin, 1 Chodźki Street, 20-093 Lublin, Poland;
| | - Iwona Piątkowska-Chmiel
- Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 8B Jaczewskiego Street, 20-090 Lublin, Poland; (M.G.-G.); (I.P.-C.); (M.H.)
| | - Mariola Herbet
- Chair and Department of Toxicology, Faculty of Pharmacy, Medical University of Lublin, 8B Jaczewskiego Street, 20-090 Lublin, Poland; (M.G.-G.); (I.P.-C.); (M.H.)
| |
Collapse
|
3
|
Biliz Y, Hasdemir B, Başpınar Küçük H, Zaim M, Şentürk AM, Müdüroğlu Kırmızıbekmez A, Kara İ. Novel N-Acyl Hydrazone Compounds as Promising Anticancer Agents: Synthesis and Molecular Docking Studies. ACS OMEGA 2023; 8:20073-20084. [PMID: 37305237 PMCID: PMC10249086 DOI: 10.1021/acsomega.3c02361] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Accepted: 05/10/2023] [Indexed: 06/13/2023]
Abstract
In this study, a new series of N-acyl hydrazones 7a-e, 8a-e, and 9a-e, starting from methyl δ-oxo pentanoate with different substituted groups 1a-e, were synthesized as anticancer agents. The structures of obtained target molecules were identified by spectrometric analysis methods (FT-IR, 11H NMR, 13C NMR, and LC-MS). The antiproliferative activity of the novel N-acyl hydrazones was evaluated on the breast (MCF-7) and prostate (PC-3) cancer cell lines by an MTT assay. Additionally, breast epithelial cells (ME-16C) were used as reference normal cells. All newly synthesized compounds 7a-e, 8a-e, and 9a-e exhibited selective antiproliferative activity with high toxicity to both cancer cells simultaneously without any toxicity to normal cells. Among these novel N-acyl hydrazones, 7a-e showed the most potent anticancer activities with IC50 values at 7.52 ± 0.32-25.41 ± 0.82 and 10.19 ± 0.52-57.33 ± 0.92 μM against MCF-7 and PC-3 cells, respectively. Also, molecular docking studies were applied to comprehend potential molecular interactions between compounds and target proteins. It was seen that the docking calculations and the experimental data are in good agreement.
Collapse
Affiliation(s)
- Yağmur Biliz
- Institute
of Graduate Studies, Istanbul University-Cerrahpaşa, Istanbul 34320, Turkey
| | - Belma Hasdemir
- Department
of Chemistry, Organic Chemistry Division, Istanbul University-Cerrahpaşa, Avcilar, Istanbul 34320, Turkey
| | - Hatice Başpınar Küçük
- Department
of Chemistry, Organic Chemistry Division, Istanbul University-Cerrahpaşa, Avcilar, Istanbul 34320, Turkey
| | - Merve Zaim
- SANKARA
Brain and Biotechnology Research Center, Entertech Technocity, Avcilar, Istanbul 34320, Turkey
| | - Ahmet Mesut Şentürk
- Department
of Pharmeceutical Chemistry, Faculty of Pharmacy, Istanbul Biruni University, Topkapı, Istanbul 34010, Turkey
| | - Aynur Müdüroğlu Kırmızıbekmez
- Department
of Physical Therapy and Rehabilitation, School of Health Sciences, Nisantasi University, Maslak, Istanbul 34398, Turkey
| | - İhsan Kara
- SANKARA
Brain and Biotechnology Research Center, Entertech Technocity, Avcilar, Istanbul 34320, Turkey
| |
Collapse
|
4
|
Nikolova-Mladenova B, Momekov G, Zhivkova Z, Doytchinova I. Design, Synthesis and Cytotoxic Activity of Novel Salicylaldehyde Hydrazones against Leukemia and Breast Cancer. Int J Mol Sci 2023; 24:ijms24087352. [PMID: 37108514 PMCID: PMC10138506 DOI: 10.3390/ijms24087352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 04/07/2023] [Accepted: 04/14/2023] [Indexed: 04/29/2023] Open
Abstract
Despite the significant advancements in complex anticancer therapy, the search for new and more efficient specific anticancer agents remains a top priority in the field of drug discovery and development. Here, based on the structure-activity relationships (SARs) of eleven salicylaldehyde hydrazones with anticancer activities, we designed three novel derivatives. The compounds were tested in silico for drug-likeness, synthesized, and evaluated in vitro for anticancer activity and selectivity on four leukemic cell lines (HL-60, KE-37, K-562, and BV-173), one osteosarcomic cell line (SaOS-2), two breast adenocarcinomic cell lines (MCF-7 and MDA-MB-231), and one healthy cell line (HEK-293). The designed compounds were found to have appropriate drug likeness and showed anticancer activities in all cell lines tested; particularly, two of them exhibited remarkable anticancer activity in nanomolar concentrations on the leukemic cell lines HL-60 and K-562 and the breast cancer MCF-7 cells and extraordinary selectivity for the same cancer lines ranging between 164- and 1254-fold. The study also examined the effects of different substituents on the hydrazone scaffold and found that the 4-methoxy salicylic moiety, phenyl, and pyridinyl rings are the most appropriate for anticancer activity and selectivity of this chemical class.
Collapse
Affiliation(s)
| | - Georgi Momekov
- Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria
| | - Zvetanka Zhivkova
- Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria
| | - Irini Doytchinova
- Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria
| |
Collapse
|
5
|
Adjissi L, Chafai N, Benbouguerra K, Kirouani I, Hellal A, Layaida H, Elkolli M, Bensouici C, Chafaa S. Synthesis, characterization, DFT, antioxidant, antibacterial, pharmacokinetics and inhibition of SARS-CoV-2 main protease of some heterocyclic hydrazones. J Mol Struct 2022; 1270:134005. [PMID: 36033106 PMCID: PMC9395430 DOI: 10.1016/j.molstruc.2022.134005] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2022] [Revised: 08/05/2022] [Accepted: 08/22/2022] [Indexed: 02/04/2023]
Abstract
Three hydrazone derivatives have been synthesized using condensation reaction of 4-hydrazinylbenzoic acid with three aromatic aldehydes namely: thiophene-2-carbaldehyde, thiophene-3-carbaldehyde and 2-furaldehyde in ethanol at 78 °C reflux. The synthesized molecules have been characterized using spectroscopic and physicochemical methods including UV-Vis, IR, 1H NMR, 13C NMR, 15N NMR and melting point determination. Optimized molecular structures, UV-Vis and IR spectra modeling, the reactivity, the stability and some quantum chemical parameters of the synthesized molecules were modeled utilizing density functional theory (DFT). The obtained theoretical results were found in good agreement with the experimental results. On the other hand, the antioxidant and antibacterial activities of the molecules under study were evaluated to better understand the associated mechanisms of action specifically. Also, predicted ADME-T and pharmacokinetic parameters indicated that these compounds showed good oral bioavailability. Finally, molecular docking has been used to predict the inhibitory activity of the studied hydrazone derivatives on the SARS-CoV-2 main protease (Mpro).
Collapse
Affiliation(s)
- Lilia Adjissi
- Laboratory of Electrochemistry of Molecular Materials and Complex (LEMMC). Department of Process Engineering, Faculty of Technology, University of Ferhat ABBAS Setif-1, El-Mabouda campus, 19000 Sétif, Algeria
| | - Nadjib Chafai
- Laboratory of Electrochemistry of Molecular Materials and Complex (LEMMC). Department of Process Engineering, Faculty of Technology, University of Ferhat ABBAS Setif-1, El-Mabouda campus, 19000 Sétif, Algeria,Corresponding author
| | - Khalissa Benbouguerra
- Laboratory of Electrochemistry of Molecular Materials and Complex (LEMMC). Department of Process Engineering, Faculty of Technology, University of Ferhat ABBAS Setif-1, El-Mabouda campus, 19000 Sétif, Algeria
| | - Imene Kirouani
- Laboratory of Electrochemistry of Molecular Materials and Complex (LEMMC). Department of Process Engineering, Faculty of Technology, University of Ferhat ABBAS Setif-1, El-Mabouda campus, 19000 Sétif, Algeria
| | - Abdelkader Hellal
- Laboratory of Electrochemistry of Molecular Materials and Complex (LEMMC). Department of Process Engineering, Faculty of Technology, University of Ferhat ABBAS Setif-1, El-Mabouda campus, 19000 Sétif, Algeria
| | - Houdheifa Layaida
- Laboratory of Electrochemistry of Molecular Materials and Complex (LEMMC). Department of Process Engineering, Faculty of Technology, University of Ferhat ABBAS Setif-1, El-Mabouda campus, 19000 Sétif, Algeria
| | - Meriem Elkolli
- Laboratory of applied microbiology, Faculty of Natural and Life Sciences, University of Setif 1, Algeria
| | - Chawki Bensouici
- Centre de Recherche en Biotechnologie, Ali Mendjli, Nouvelle Ville UV 03, BP E73 Constantine, Algeria
| | - Salah Chafaa
- Laboratory of Electrochemistry of Molecular Materials and Complex (LEMMC). Department of Process Engineering, Faculty of Technology, University of Ferhat ABBAS Setif-1, El-Mabouda campus, 19000 Sétif, Algeria
| |
Collapse
|
6
|
Aydın E, Şentürk AM, Küçük HB, Güzel M. Cytotoxic Activity and Docking Studies of 2-arenoxybenzaldehyde N-acyl Hydrazone and 1,3,4-Oxadiazole Derivatives against Various Cancer Cell Lines. Molecules 2022; 27:7309. [PMID: 36364134 PMCID: PMC9657749 DOI: 10.3390/molecules27217309] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Revised: 10/24/2022] [Accepted: 10/24/2022] [Indexed: 08/25/2023] Open
Abstract
To understand whether previously synthesized novel hydrazone and oxadiazole derivatives have promising anticancer effects, docking studies and in vitro toxicity assays were performed on A-549, MDA-MB-231, and PC-3 cell lines. The antiproliferative properties of the compounds were investigated using molecular docking experiments. Each compound's best-docked poses, binding affinity, and receptor-ligand interaction were evaluated. Compounds' molecular weights, logPs, TPSAs, abilities to pass the blood-brain barrier, GI absorption qualities, and CYPP450 inhibition have been given. When the activities of these molecules were examined in vitro, for the A-549 cell line, hydrazone 1e had the minimum IC50 value of 13.39 μM. For the MDA-MB-231 cell line, oxadiazole 2l demonstrated the lowest IC50 value, with 22.73 μM. For PC-3, hydrazone 1d showed the lowest C50 value of 9.38 μM. The three most promising compounds were determined as compounds 1e, 1d, and 2a based on their minimum IC50 values, and an additional scratch assay was performed for A-549 and MDA-MB-231 cells, which have high migration capacity, for the three most potent molecules; it was determined that these molecules did not show a significant antimetastatic effect.
Collapse
Affiliation(s)
- Esranur Aydın
- Center of Drug Discovery and Development, Research Institute for Health Sciences and Technologies SABITA, Istanbul Medipol University, 34810 Istanbul, Turkey
- Department of Molecular Medicine, and Biotechnology, Health Sciences Institute, Istanbul Medipol University, 34810 Istanbul, Turkey
| | - Ahmet Mesut Şentürk
- Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul Biruni University, 34010 Istanbul, Turkey
| | - Hatice Başpınar Küçük
- Department of Chemistry, Faculty of Engineering, Organic Chemistry Division, Istanbul University-Cerrahpasa, 34320 Istanbul, Turkey
| | - Mustafa Güzel
- Center of Drug Discovery and Development, Research Institute for Health Sciences and Technologies SABITA, Istanbul Medipol University, 34810 Istanbul, Turkey
- Department of Molecular Medicine, and Biotechnology, Health Sciences Institute, Istanbul Medipol University, 34810 Istanbul, Turkey
- Department of Basic Pharmaceutical Sciences, School of Pharmacy, Istanbul Medipol University, 34810 Istanbul, Turkey
| |
Collapse
|
7
|
Gallium (III) Complexes with 5-Bromosalicylaldehyde Benzoylhydrazones: In Silico Studies and In Vitro Cytotoxic Activity. Molecules 2022; 27:molecules27175493. [PMID: 36080261 PMCID: PMC9457627 DOI: 10.3390/molecules27175493] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Revised: 08/17/2022] [Accepted: 08/24/2022] [Indexed: 01/18/2023] Open
Abstract
Gallium (III) complexes with the ligands 5-bromosalicylaldehyde-4-hydroxybenzoylhydrazone and 5-bromosalicylaldehyde isonicotinoylhydrazone were synthesized to receive compounds with improved antiproliferative action. Compounds were characterized by elemental analysis, IR, and NMR spectroscopy. Density functional theory calculations with Becke’s 3-parameter hybrid functional and 6-31+G(d,p) basis set were carried out to investigate the structural features of the ligands and Ga(III) complexes. Cytotoxic screening by MTT-dye reduction assay was carried out using cisplatin and melphalan as reference cytotoxic agents. A general formula [Ga(HL)2]NO3 for the complexes obtained was suggested. The complexes are mononuclear with the Ga(III) ions being surrounded by two ligands. The ligands acted as monoanionic tridentate (ONO) donor molecules. The analysis revealed coordination binding through deprotonated phenolic-oxygen, azomethine-nitrogen, and amide-oxygen atoms. The bioassay demonstrated that all compounds exhibited concentration-dependent antiproliferative activity at low micromolar concentrations against the acute myeloid leukemia HL-60 and T-cell leukemia SKW-3 cell lines. IC50 values of 5-bromo-derivative ligands and gallium (III) complexes are lower than those of cisplatin and much lower than these of melphalan. The coordination to gallium (III) additionally increased the cytotoxicity compared to the metal-free hydrazones.
Collapse
|
8
|
Hristova-Avakumova NG, Valcheva EP, Anastassova NO, Nikolova-Mladenova BI, Atanasova LA, Angelova SE, Yancheva DY. In vitro and in silico studies of radical scavenging activity of salicylaldehyde benzoylhydrazones. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.131021] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
9
|
Mourad AA, Rizzk YW, Zaki I, Mohammed FZ, El Behery M. Synthesis and cytotoxicity screening of some synthesized hybrid nitrogen molecules as anticancer agents. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.130722] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
10
|
Popiołek Ł, Patrejko P, Gawrońska-Grzywacz M, Biernasiuk A, Berecka-Rycerz A, Natorska-Chomicka D, Piątkowska-Chmiel I, Gumieniczek A, Dudka J, Wujec M. Synthesis and in vitro bioactivity study of new hydrazide-hydrazones of 5-bromo-2-iodobenzoic acid. Biomed Pharmacother 2020; 130:110526. [DOI: 10.1016/j.biopha.2020.110526] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2020] [Revised: 07/10/2020] [Accepted: 07/11/2020] [Indexed: 01/08/2023] Open
|
11
|
Popiołek Ł, Rysz B, Biernasiuk A, Wujec M. Synthesis of promising antimicrobial agents: hydrazide‐hydrazones of 5‐nitrofuran‐2‐carboxylic acid. Chem Biol Drug Des 2019; 95:260-269. [DOI: 10.1111/cbdd.13639] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2019] [Revised: 08/08/2019] [Accepted: 09/21/2019] [Indexed: 12/26/2022]
Affiliation(s)
- Łukasz Popiołek
- Department of Organic Chemistry Faculty of Pharmacy with Medical Analytics Division Medical University of Lublin Lublin Poland
| | - Bernadetta Rysz
- Department of Organic Chemistry Faculty of Pharmacy with Medical Analytics Division Medical University of Lublin Lublin Poland
| | - Anna Biernasiuk
- Department of Pharmaceutical Microbiology Faculty of Pharmacy with Medical Analytics Division Medical University of Lublin Lublin Poland
| | - Monika Wujec
- Department of Organic Chemistry Faculty of Pharmacy with Medical Analytics Division Medical University of Lublin Lublin Poland
| |
Collapse
|
12
|
Iliev I, Kontrec D, Detcheva R, Georgieva M, Balacheva A, Galić N, Pajpanova T. Cancer cell growth inhibition by aroylhydrazone derivatives. BIOTECHNOL BIOTEC EQ 2019. [DOI: 10.1080/13102818.2019.1608302] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
Affiliation(s)
- Ivan Iliev
- Department of Pathology, Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Sofia, Bulgaria
- Department of Molecular Design and Biochemical Pharmacology, Institute of Molecular Biology “Roumen Tsanev” Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Darko Kontrec
- Laboratory for Stereoselective Catalysis and Biocatalysis Division of Organic Chemistry and Biochemistry, Ruđer Bošković Institute, Zagreb, Croatia
| | - Roumiana Detcheva
- Department of Molecular Design and Biochemical Pharmacology, Institute of Molecular Biology “Roumen Tsanev” Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Maya Georgieva
- Department of Molecular Design and Biochemical Pharmacology, Institute of Molecular Biology “Roumen Tsanev” Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Anelia Balacheva
- Department of Molecular Design and Biochemical Pharmacology, Institute of Molecular Biology “Roumen Tsanev” Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Nives Galić
- Division of Analytical Chemistry, Department of Chemistry, Faculty of Science, University of Zagreb, Zagreb, Croatia
| | - Tamara Pajpanova
- Department of Molecular Design and Biochemical Pharmacology, Institute of Molecular Biology “Roumen Tsanev” Bulgarian Academy of Sciences, Sofia, Bulgaria
| |
Collapse
|